Sort
15,842 grants matching “pancreatic cancer”
Dissecting ALK4 Function in Cancer Progression
$207,495Gerard C Blobe · Duke University · R21 · FY2015 · CA
GPCR regulation of progenitor cells in pancreatic cancer
$207,495Rolf A Brekken · Ut Southwestern Medical Center · R21 · FY2012 · CA
Axl as a target for the therapy of pancreatic cancer
$207,495Rolf A Brekken · Ut Southwestern Medical Center · R21 · FY2013 · CA
Role of cell cycle withdrawal in restricting pancreatic cancer progression.
$207,312Gregory David · New York University School Of Medicine · R21 · FY2013 · CA
Career Development Program
$207,243Donald J Buchsbaum · University Of Alabama At Birmingham · P50 · FY2011 · CA
GEMZAR--MECHANISMS OF CYTOTOXICITY &RADIOSENSITIZATION
$207,241University Of Michigan At Ann Arbor · R01 · FY2001 · CA
Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis
$207,122Anna S Gukovskaya · University Of California Los Angeles · P01 · FY2014 · CA
Targeting Cancer-Associated Myofibroblasts by DNA Hypomethylation
$207,074Benjamin Tycko · Columbia University Health Sciences · U54 · FY2012 · CA
Development of ESiPSC approach for non-germline GEM modelling
$207,012Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Core B - Tissue Procurement, Pathology, and Genomics
$206,965Alina Iuga · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Alchol Abuse and Metabolic Syndrome Promote Desmoplasia of Pancreatic Cancer
$206,940Stephen J Pandol · University Of California Los Angeles · P01 · FY2012 · CA
Core B: Preclinical Therapeutics Core
$206,938Cyril Henri Benes · University Of Tx Md Anderson Can Ctr · P01 · FY2016 · CA
Inflammatory processes In diet-Induced pancreatic cancer promotion
$206,876Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2012 · CA
Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life
$206,869James H Flory · Sloan-Kettering Inst Can Research · R21 · FY2025 · CA
Engineered exosome mimetics as targeted biological nanomedicines for pancreatic cancer
$206,869Marsha A Moses · Boston Children'S Hospital · R21 · FY2025 · CA
Proteomic Characterization of Pancreatic Neuroendocrine Tumors and Metastatic Progression
$206,869Michael H. A. Roehrl · Sloan-Kettering Inst Can Research · R21 · FY2021 · CA
Elucidating and targeting epigenetic oncogenic networks in pancreatic cancer
$206,843Alexandros Tzatsos · George Washington University · R21 · FY2015 · CA
A RAS-FAM83A Regulatory Loop as a Novel Therapeutic Target for Pancreatic Cancer
$206,843Mark W Jackson · Case Western Reserve University · R21 · FY2013 · CA
Next-generation mouse gene-targeting technology to model tumorigenesis
$206,843Zhenghe Wang · Case Western Reserve University · R21 · FY2015 · CA
Non-invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer
$206,843Charles Scott Craik · University Of California, San Francisco · R21 · FY2016 · CA
Synthesis of Various C-Linked Glycopeptides of Biomedical Interest
$206,810Ernest G Nolen · Colgate University · R15 · FY2008 · GM
Core C: Computational Core
$206,784Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
Bioinformatics Shared Resource
$206,766Jean-Pierre A Kocher · Mayo Clinic Rochester · P30 · FY2022 · CA
HDAC6-Selective Inhibitors for Pancreatic Cancer Treatment
$206,721Werner Tueckmantel · Psychogenics, Inc. · R43 · FY2008 · CA
Mass Spec Proteomics
$206,651Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2015 · CA